Validation of Clean Rooms within Gene Therapy Innovation and Manufacturing Centre - Phase 2

To validate and qualify the equipment and clean rooms at GTIMC. This step is essential for getting the Centre ready for MHRA inspection and issuing the license to allow GTIMC manufacture clinical vectors for human clinical trials.

This is a follow on contract from 3230/SSA/JS which was awarded against a 'Negotiated Procedure without a call for competition' which was previously published as a Voluntary ex ante transparency notice (reference: 2022/S 000-002231). Regulation 32 of PCR 2015 was applied as in 31. (2) (b) (ii). This award notice is for Phase 2 of the project